Xeris制药(纳斯达克代码:XERS)计划于2026年3月2日发布其2025财年全年财务报告,并同时公布对2026财年的业绩展望。该公告将详细披露公司过去一年的经营成果,并为新财年的发展路径提供明确指引。
Xeris制药(纳斯达克代码:XERS)计划于2026年3月2日发布其2025财年全年财务报告,并同时公布对2026财年的业绩展望。该公告将详细披露公司过去一年的经营成果,并为新财年的发展路径提供明确指引。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.